Literature DB >> 19184183

Comparison of clinical characteristics and frequency of adverse outcomes in patients with Marfan syndrome diagnosed in adulthood versus childhood.

Lisa Willis1, Genie E Roosevelt, Anji T Yetman.   

Abstract

Patients with Marfan syndrome (MFS) continue to elude diagnosis until well into adulthood. The purpose of this study was to compare the clinical characteristics and outcomes of adult survivors with MFS diagnosed during adulthood (age, >or=18 years) with those of adult survivors with MFS diagnosed in childhood (<18 years). We conducted a retrospective review of 66 adult (age, >18 years) MFS patients seen at a combined pediatric and adult multidisciplinary MFS clinic from 2004 to 2006. Demographic, clinical, and cardiac variables were collected and a comparative analysis was performed between the two groups: patients diagnosed with MFS during childhood and patients diagnosed in adulthood. The primary outcome measures were the presence of aortic dissection and the need for urgent cardiovascular surgery. Despite a similar incidence of clinical characteristics, 39 of the 66 MFS patients were not diagnosed until adulthood. The overall incidence of major cardiac involvement was comparable between the two groups, although the patients diagnosed at a younger age were found to have a reduced need for aortic surgery (33% vs. 59%; P < 0.04) and fewer adverse cardiac outcomes (0% vs. 46%; P < 0.001). Moreover, the patients diagnosed with MFS in adulthood were more likely to require repeated surgical intervention for distal aortic disease (13% vs. 0%; P = 0.07). In conclusion, patients with MFS who remain undiagnosed until adulthood have well-established cardiovascular pathology frequently requiring surgical intervention. Due to this delay in diagnosis and management, they often suffer from a suboptimal clinical outcome. Our research demonstrates the importance of educating pediatric clinicians in early MFS diagnosis in hopes of improving the long-term outcome of all MFS patients.

Entities:  

Mesh:

Year:  2009        PMID: 19184183     DOI: 10.1007/s00246-008-9346-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  8 in total

1.  Comparison of outcome of the Marfan Syndrome in patients diagnosed at age < or =6 years versus those diagnosed at >6 years of age.

Authors:  Anji T Yetman; Pip Huang; Renee A Bornemeier; Brian W McCrindle
Journal:  Am J Cardiol       Date:  2003-01-01       Impact factor: 2.778

2.  Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.

Authors:  Anji T Yetman; Renee A Bornemeier; Brian W McCrindle
Journal:  Am J Cardiol       Date:  2005-05-01       Impact factor: 2.778

Review 3.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

4.  Long-term results of aortic valve-sparing operations for aortic root aneurysm.

Authors:  Tirone E David; Christopher M Feindel; Gary D Webb; Jack M Colman; Susan Armstrong; Manjula Maganti
Journal:  J Thorac Cardiovasc Surg       Date:  2006-07-10       Impact factor: 5.209

5.  Revised diagnostic criteria for the Marfan syndrome.

Authors:  A De Paepe; R B Devereux; H C Dietz; R C Hennekam; R E Pyeritz
Journal:  Am J Med Genet       Date:  1996-04-24

6.  Evolving phenotype of Marfan's syndrome.

Authors:  K J Lipscomb; J Clayton-Smith; R Harris
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

7.  Natural history of cardiovascular manifestations in Marfan syndrome.

Authors:  C D van Karnebeek; M S Naeff; B J Mulder; R C Hennekam; M Offringa
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

8.  Aortic root replacement in patients with Marfan's syndrome: the Southampton experience.

Authors:  C Alexiou; S M Langley; P Charlesworth; M P Haw; S A Livesey; J L Monro
Journal:  Ann Thorac Surg       Date:  2001-11       Impact factor: 4.330

  8 in total
  3 in total

Review 1.  Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine.

Authors:  Alain Li-Wan-Po; Bart Loeys; Peter Farndon; David Latham; Caroline Bradley
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

2.  Marfan syndrome affecting a whole Sudanese family.

Authors:  Laila M Elmahdi; Sulafa Km Ali
Journal:  Sudan J Paediatr       Date:  2013

3.  Characterization of pain, disability, and psychological burden in Marfan syndrome.

Authors:  Traci J Speed; Vani A Mathur; Matthew Hand; Bryt Christensen; Paul D Sponseller; Kayode A Williams; Claudia M Campbell
Journal:  Am J Med Genet A       Date:  2016-11-14       Impact factor: 2.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.